Idk about everyone’s watchlists but I know mine were heavily in the red today, including bd1 which quite frankly I didn’t see as being too much in the red today.
Today’s standardised test is the ca125. Our test has just confirmed it can do a better job than ca125, but again, needs further studies and clinical validation, just like CancerSEEK. This means that it’s still early days for both CancerSEEK and Bard1.
Besides, there is a chance that both tests are holding key pieces of the puzzle as Bard1 has been a good identifier for cancer anomalies.
I’m glad bd1 hasn’t popped yet, otherwise I wouldn’t have been in st my cheap entry point of .014. At these levels, I don’t think there is much difference between 7-10M market cap size.
Patience anyone?
Gltah and dyor
Idk about everyone’s watchlists but I know mine were heavily in...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
-0.005(1.04%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.0¢ | 47.5¢ | $30.94K | 64.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20936 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.0¢ | 40000 | 1 |
View Market Depth
| Last trade - 15.41pm 03/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |